Apoptosis as a novel target for cancer chemoprevention

Journal of the National Cancer Institute

Volumn 96, Issue 9, 2004, Pages 662-672

  Sun, Shi Yong ^a   Hail Jr , Numsen ^a   Lotan, Robert ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALITRETINOIN; ANTINEOPLASTIC AGENT; CAFFEIC ACID DERIVATIVE; CAPSAICIN; CELECOXIB; CLOMIFENE; CURCUMIN; DEGUELIN; EFLORNITHINE; EPIGALLOCATECHIN GALLATE; FENRETINIDE; MESALAZINE; NAFOXIDINE; PERILLYL ALCOHOL; PHENYLETHYL 3 METHYLCAFFEATE; POLYPHENOL DERIVATIVE; QUERCETIN; RESINIFERATOXIN; RESVERATROL; RETINOIC ACID; ROTENONE; RUTOSIDE; S ADENOSYLMETHIONINE; SELENIUM; SULINDAC; SULINDAC SULFONE; TAMOXIFEN; TRIBUTYRIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADENOMATOUS POLYP; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER PREVENTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL; COLON CARCINOGENESIS; COLORECTAL CANCER; DNA DAMAGE; DRUG MECHANISM; ESOPHAGUS CANCER; HUMAN; IN VIVO STUDY; LEUKEMIA CELL; LIVER CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SKIN TUMOR; TONGUE CANCER; TUMOR CELL; ANIMAL; DRUG EFFECT; NEOPLASM;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CLINICAL TRIALS; HUMANS; NEOPLASMS;

EID: 2442561553     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh123     Document Type: Review

References (179)

1. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997;278:1073-7.
2. Bertram JS. The molecular biology of cancer. Mol Aspects Med 2000; 21:167-223.
3. Berenblum I, Armuth V. Two independent aspects of tumor promotion. Biochim Biophys Acta 1981;651:51-63.
4. Heidelberger C, Freeman AE, Pienta R, Sivak A, Bertram JS, Casto BC, et al. Cell transformation by chemical agents - a review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res 1983;114:283-385.
5. Surh Y-J. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic compounds. Mutat Res 1999; 428:305-27.
6. Sporn MB. Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 1976;36:2699-702.
7. Umar A, Viner JL, Hawk ET. The future of colon cancer prevention. Ann NY Acad Sci 2001;952:88-108.
8. Kelloff GJ, Lieberman R, Steele VE, Boone CW, Lubet RA, Kopelovich L, et al. Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer. Urology 2001;57:46-51.
9. Kakizoe T. Chemoprevention of cancer - focusing on clinical trials. Jpn J Clin Oncol 2003;33:421-42.
10. Wattenberg LW. What are the critical attributes for cancer chemopreventive agents? Ann NY Acad Sci 1995;768:73-81.
11. Smith TJ, Hong J-Y, Wang Z-Y, Yang CS. How can carcinogenesis be inhibited? Ann NY Acad Sci 1995;768:82-90.
12. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Boone CW, Malone WA, et al. Progress in cancer chemoprevention. Ann NY Acad Sci 1999;889: 1-13.
13. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002;94:252-66.
14. Fabian CJ, Kimler BF. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention. Ann NY Acad Sci 2001;952:44-59.
15. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281:1312-6.
16. Hill LL, Ouhtit A, Loughlin SM, Kripke ML, Ananthaswamy HN, Owen-Schaub LB. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 1999;285:898-900.
17. Costantini P, Jocotot E, Decaudin D, Kroemer G. Mitochondrion as a novel target of anticancer chemotherapy. J Natl Cancer Inst 2000;92: 1042-53.
18. Reed JC. Apoptosis-targeted therapies for cancer. Cancer Cell 2002;3: 17-22.
19. Cantley LC, Neel BG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/ AKT pathway. Proc Natl Acad Sci USA 1999;96:4240-5.
20. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 19970:323-31.
21. Reed JC. Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol 1999;11:68-75.
22. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 2001;98:10350-5.
23. Lu Y-P, Lou Y-R, Li XH, Xie J-G, Brash D, Huang M-T, et al. Stimulatory effect of oral administration of green tea or caffeine on ultraviolet light-induced increases in epidermal wild-type p53, p21 (WAF1/CIP1), and apoptotic sunburn cells in SKH-1 mice. Cancer Res 2000;60:4785-91.
24. Lu Y-P, Lou Y-R, Xie J-G, Yen P, Huang M-T, Conney AH. Inhibitory effect of black tea on the growth of established skin tumors in mice: effects on tumor size, apoptosis, mitosis and bromodeoxyuridine incorporation into DNA. Carcinogenesis 1997;18:2163-9.
25. Klaunig JE, Kamendulis LM. Mechanisms of cancer chemoprevention in hepatic carcinogenesis: modulation of focal lesion growth in mice. Toxicol Sci 1999;52:101-6.
26. Lu Y-P, Lou Y-R, Xie J-G, Q-Y P, Liao J, Yang CS, et al. Topical application of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA 2002;99:12455-60.
27. Pascale RM, Simile MM, De Miglio MR, Nufris A, Daino L, Seddaiu MA, et al. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. Carcinogenesis 1995;16:427-30.
28. Mahmoud NN, Dannenberg AJ, Mestre J, Bilinski RT, Churchill MR, Martucci C, et al. Aspirin prevents tumors in a murine model of familial adenomatous polyposis. Surgery 1998;124:225-31.
29. Reddy BS, Wang CX, Samaha H, Lubet R, Steele VE, Kelloff GJ, et al. Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res 1997;57:420-5.
30. Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 1997;57:1301-5.
31. Yang K, Lamprecht SA, Liu Y, Shinozaki H, Fan K, Leung D, et al. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 2000;21:1655-60.
32. Fong LY, Nguyen VT, Pegg AE, Magee PN. Alpha-difluoromethylornithine induction of apoptosis: a mechanism which reverses pre-established cell proliferation and cancer initiation in esophageal carcinogenesis in zinc-deficient rats. Cancer Epidemiol Biomarkers Prev 2001;10:191-9.
33. Tanaka T, Kohno H, Sakata K, Yamada Y, Hirose Y, Sugie S, et al. Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Carcinogenesis 2002;23:1361-7.
34. Isenberg JS, Kolaja KL, Ayoubi AS, Watkins JB, 3rd, Klaunig JE. Inhibition of WY-14,643 induced hepatic lesion growth in mice by rotenone. Carcinogenesis 1997;18:1511-9.
35. Bus PJ, Nagtegaal ID, Verspaget HW, Lamers CB, Geldof H, Van Krieken JH, et al. Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemnopreventive era. Aliment Pharmacol Ther 1999; 13:1397-402.
36. Reinacher-Schick A, Seidensticker F, Petrasch S, Reiser M, Philippou S, Theegarten D, et al. Mesalazine changes apoptosis and proliferation in normal mucosa of patients with sporadic polyps of the large bowel. Endoscopy 2000;32:245-54.
37. van Stolk R, Stoner G, Hayton WL, Chan K, DeYoung B, Kresty L, et al. Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis. Clin Cancer Res 2000;6:78-89.
38. Kelloff GJ, Johnson JR, Crowell JA, Boone CW, DeGeorge JJ, Steele VE, et al. Approaches to the development and marketing approval of drugs that prevent cancer. Cancer Epidemiol Biomarkers Prev 1995;4:1-10.
39. Trock BJ. Validation of surrogate endpoint biomarkers in prostate cancer chemoprevention. Urology 2001;57:241-57.
40. Greenwald P. Cancer prevention clinical trials. J Clin Oncol 2002;20:14s-22s.
41. Kania J, Konturek SJ, Marlicz K, Hahn EG, Konturek PC. Expression of survivin and caspase-3 in gastric cancer. Dig Dis Sci 2003;48:266-71.
42. Caulin C, Salvesen GS, Oshima G. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J Cell Biol 1997;138:1379-94.
43. Urosevic M, Maier T, Benninghoff B, Slade H, Burg G, Dummer R. Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol 2003;139:1325-32.
44. Henderson PJF, Lardy HA. Bongkrekic acid an inhibitor of the adenine nucleotide translocase of mitochondria. J Biol Chem 1970;245:1319-26.
45. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-776.
46. Ferri KF, Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001;3:E255-E263.
47. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998;281:1305-8.
48. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491-501.
49. Lou X, Kim CN, Yang J, Jemmerson R, Wang X. Bid, a Bcl-2 interacting protein, mediates cytochrome c release from the mitochondria in response to activation of cell surface death receptors. Cell 1998;94:481-90.
50. Li LY, Lou X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001;412:95-9.
51. van Loo G, Schotte P, van Gurp M, Demol H, Hoorelbeke B, Gevaert K, et al. Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. Cell Death Differ 2001;8:1136-42.
52. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999;399:483-7.
53. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996;86:147-57.
54. Chai J, Du C, Wu JW, Kyin S, Wang X, Shi Y. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 2000;406:855-62.
55. van Loo G, van Gurp M, Depuydt B, Srinivasula SM, Rodriguez I, Alnemri ES, et al. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi/HtrA2 interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ 2002;9:20-7.
56. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999;397:441-6.
57. Wu M, Xu L-G, Li X, Zhai Z, Shu H-B. AMID, an apoptosis-inducing factor-homologues mitochondrion-associated protein, induces caspase-independent apoptosis. J Biol Chem 2002;277:25617-23.
58. Adams JM, Cory S. The bcl-2 protein family: arbiters of cell survival. Science 1998;281:1322-6.
59. Reed JC, Jurgensmeier JM, Matsuyama S. Bcl-2 family proteins and mitochondria. Biochim Biophys Acta 1998;1366:127-37.
60. Zoratti M, Szabò I. The mitochondrial permeability transition. Biochim Biophys Acta 1995;1241:139-76.
61. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem 1992;67:8834-9.
62. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281: 1309-12.
63. Schneider SM, Offterdinger M, Huber H, Grunt TW. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells. Cancer Res 2000;60:5479-87.
64. Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Jr, Grignani F, et al. N-(4-Hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res 1993;53:6036-41.
65. Hail N, Jr., Lotan R. Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenly)retinamide-induced apoptosis. Cancer Epidemiol Biomarkers Prev 2000;9:1293-301.
66. Oridate N, Lotan D, Xu XC, Hong WK, Lotan R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res 1996;2:855-63.
67. Maurer B, Metelitsa L, Seeger R, Cabot M, Reynolds C. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)retinamide in neuroblastoma cell lines. J Natl Cancer Inst 1999;91:1138-46.
68. Sun S-Y, Yue P, Lotan R. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis related genes in human prostate carcinoma cells. Mol Pharmacol 1999;55:403-10.
69. Huang Y, He Q, Hillman MJ, Rong R, Sheikh MS. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells. Cancer Res 2001;61: 6918-24.
70. Lim JT, Piazza GA, Han EK, Delohery TM, Li H, Finn TS, et al. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochem Pharmacol 1999;58:1097-107.
71. Rahman MA, Dhar DK, Masunaga R, Yamanoi A, Kohno H, Nagasue N. Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepatocellular carcinoma cell lines. Cancer Res 2000;60:2085-9.
72. Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B. Role of BAX in the apoptotic response to anticancer agents. Science 2000;290:989-92.
73. Hsu AL, Ching TT, Wang DS. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 2000;275:11397-403.
74. Dietze EC, Caldwell LE, Grupin SL, Mancini M, Seewaldt VL. Tamoxifen but not 4-hydroxytamoxifen initiates apoptosis in p53(-) normal human marnmary epithelial cells by inducing mitochondrial depolarization. J Biol Chem 2001;276:5384-94.
75. Ferlini C, Scambia G, Marone M, Distefano M, Gaggini C, Ferrandina G, et al. Tamoxifen induces oxidative stress and apoptosis in oestrogen receptor-negative human cancer cell lines. Br J Cancer 1999;79:257-63.
76. Kang Y, Cortina R, Perry RR. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. J Natl Cancer Inst 1996;98:279-84.
77. Okamura T, Masuda M, Arai Y, Ishida C, Shudou K, Mizoguchi H. All-trans retinoic acid modulates Fas antigen expression and affects cell proliferation and apoptosis in combination with anti-Fas monoclonal antibody in the human myeloma cell line, U266B1. Exp Hematol 1998; 26:501-6.
78. Hayakawa S, Saeki K, Sazuka M, Suzuki Y, Shoji Y, Ohta T, et al. Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem Biophys Res 2001;285:1102-6.
79. Oridate N, Suzuki S, Higuchi M, Mitchell MF, Hong WK, Lotan R. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J Natl Cancer Inst 1997;89:1191-8.
80. Chan TA, Morin P, Vogelstein B, Kinzler KW. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 1998;95:681-6.
81. Kusuhara H, Komatsu H, Sumichika H, Sugahara K. Reactive oxygen species are involved in the apoptosis induced by nonsteroidal antiinflammatory drugs in cultured gastric cells. Eur J Pharmacol 1999;383: 331-7.
82. 2 production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 2000;21:2035-9.
83. Morin D, Barthelemy S, Zini R, Labidalle S, Tillement JP. Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation. FEBS Lett 2001;495:131-6.
84. 2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res 2000;60:5995-6000.
85. Macho A, Calcado MA, Muñoz-Blanco J, Gómez-Díaz C, Gajate C, Mollinedo F, et al. Selective induction of apoptosis by capsaicin in transformed cells: the role of reactive oxygen species and calcium. Cell Death Differ 1999;6:155-65.
86. Hail N, Jr., Lotan R. Examining the role of mitochondrial respiration in vanilloid-induced apoptosis. J Natl Cancer Inst 2002;94:1281-92.
87. Macho A, Blázquez M-V, Navas P, Muñoz E. Induction of apoptosis by vanilloid compounds does not require de novo gene transcription and activator protein 1 activity. Cell Growth Differ 1998;9:277-86.
88. Richeux F, Cascante M, Ennamany R, Sanchez D, Sanni A, Saboureau D, et al. Implication of oxidative stress and inflammatory process in the toxicity of capsaicin in human endothelial cells: lack of DNA strand breakage. Toxicology 2000;147:41-9.
89. Macho A, Lucena C, Calzado MA, Blanco M, Donnay I, Appendino G, et al. Phorboid 20-homovanillates induce apoptosis through a VR1-independent mechanism. Chem Biol 2000;7:493-92.
90. Armstrong JS, Hornung B, Lecane P, Jones DP, Knox SJ. Rotenone-induced G2/M cell cycle arrest and apoptosis in a human B lymphoma cell line PW. Biochem Biophys Res 2001;289:973-8.
91. Isenberg JS, Klaunig JE. Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells. Toxicol Sci 2000;53:340-51.
92. Hail N, Jr., Lotan R. Apoptosis induction by the natural product cancer chemopreventive agent deguelin is mediated through the inhibition of mitochondrial bioenergetics. Apoptosis. In press. 2004.
93. Fleury C, Mignotte B, Vayssière JL. Mitochondrial reactive species in cell death signaling. Biochimie 2002;84:131-41.
94. Skulachev VP. Mitochondrial physiology and pathology: concepts of programmed cell death of organelles, cells, and organisms. Mol Aspects Med 1999;20:139-84.
95. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 1997;17:3-7.
96. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527-605.
97. Skulachev VP. Why are mitochondria involved in apoptosis? FEBS Lett 1996;397:7-10.
98. Hail N. Jr., Lotan R. Mitochondrial respiration is uniquely associated with the prooxidant and apoptotic effects of N-(4-hydroxyphenyl)retinamide. J Biol Chem 2001;276:45614-21.
99. Dedov VN, Mandadi S, Armati PJ, Verkhratski A. Capsaicin-induced depolarization of mitochondria in dorsal root ganglion neurons is enhanced by vanilloid receptors. Neuroscience 2001;103:219-26.
100. Singh KK, Russell J, Sigala B, Zhang Y, Wiliams J, Keshav KF. Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene 1999;18:6641-6.
101. Joshi B, Li L, Taffe BG, Zhu Z, Wahl S, Tian H, et al. Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid containing hydroxamic acid), requires the mitochondrial respiratory chain. Cancer Res 1999;59:4343-55.
102. Poppe M, Reimertz C, Munstermann G, Kogel D, Prehn JH. Ceramide-induced apoptosis of D283 medulloblastoma cells requires mitochondrial respiratory chain activity but occurs independently of caspases and is not sensitive to Bcl-xL overexpression. J Neurochem 2002;82:482-94.
103. Higuchi M, Aggarwal BB, Yeh ET. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest 1997;99:1751-8.
104. Kim J-Y, Kim Y-H, Chang I, Kim S, Pak YK, Oh B-H, et al. Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis. Oncogene 2002;21:3139-48.
105. Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci 1999;24:68-72.
106. Cavalli LR, Liang BC. Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved? Mutat Res 1998;398:19-26.
107. John AP. Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer. Med Hypotheses 2001;57:429-31.
108. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
109. Mathupala SP, Rempel A, Pedersen PL. Glucose catabolism in cancer cells. J Biol Chem 1995;270:16918-25.
110. Bauer MKA, Vogt M, Los M, Siegel J, Wesselborg S, Schulze-Osthoff K. Role of reactive oxygen intermediates in activation-induced CD95 (APO-1/Fas) ligand expression. J Biol Chem 1998;273:8048-55.
111. Bouvard V, Zaitchouk T, Vacher M, Duthu A, Canivet M, Choisy-Rossi C, et al. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionizing irradiation in mice. Oncogene 2000;19:649-60.
112. Kwon D, Choi C, Lee J, Kim KO, Kim JD, Kim SJ, et al. Hydrogen peroxide triggers the expression of Fas/FasL in astrocytoma cell lines and augments apoptosis. J Neuroimmunol 2001;113:1-9.
113. Andoh T, Lee SY, Chiueh CC. Preconditioning regulation of bcl-2 and p66shc by human NOS1 enhances tolerance to oxidative stress. FASEB J 2000;14:2144-6.
114. Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K, et al. Endothelial apoptosis induced by oxidative stress through activation of NF-κB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension 2001:38:48-55.
115. Bojes HK, Datta K, Xu J, Chin A, Simonian P, Nunez G, et al. Bcl-xL overexpression attenuates glutathione depletion in FL5. 12 cells following interteukin-3 withdrawal. Biochem J 1997;325:315-9.
116. Crawford MJ, Krishnamoorthy RR, Rudick VL, Collier RJ, Kapin M, Aggarwal BB, et al. Bcl-2 overexpression protects photooxidative stress-induced apoptosis of photoreceptor cells via NF-κB preservation. Biochem Biophys Res 2001;281:1304-12.
117. Sonoda Y, Watanabe S, Matsumoto Y, Aizu-Yokota E, Kasahara T. FAK is the upstream signal protein of the phosphatidylinositol 3-kinase-Akt survival pathway in hydrogen peroxide-induced apoptosis of a human glioblastoma cell line. J Biol Chem 1999;274:10566-70.
118. Longoni B, Boschi E, Demontis GC, Ratto GM, Mosca F. Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL-2 expression levels. FASEB J 2001;15:731-40.
119. Zhou XM, Wong BC, Fan XM, Zhang HB, Lin MC, Kung HF, et al. Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis 2001;22: 1393-7.
120. Zhang W, Couldwell WT, Song H, Takano T, Lin JH, Nedergaard M. Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Cancer Res 2000;60:5395-400.
121. Jung M-Y, Kang H-J, Moon A. Capsaicin-induced apoptosis in SK-Hep-1 hepatocarcinoma cells involves Bcl-2 downregulation and caspase-3 activation. Cancer Lett 2001;165:139-45.
122. Chun K-H, Kosmeder JW, Sun S, Pezzuto JM, Lotan R, Hong WK, et al. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Natl Cancer Inst 2003;95:291-302.
123. Li Y, Upadhyay S, Bhuiyan M, Sarkar FH. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 1999;18:3166-72.
124. Ahmad N, Gupta S, Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappa B in cancer cells versus normal cells. Arch Biochem Biophys 2000;376:338-46.
125. Cipriani B, Borsellino G, Knowles H, Tramonti D, Cavaliere F, Bernardi G, et al. Curcumin inhibits activation of Vγ9Vδ2 T cells by phosphoantigens and induces apoptosis involving apoptosis-inducing factor and large scale DNA fragmentation. J Immunol 2001;167:3454-62.
126. Holmes-McNary M, Baldwin AS, Jr. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res 2000;60:3477-83.
127. Davis JN, Kucuk O, Sarkar FH. Genistein inhibits NF-kB activation in prostate cancer cells. Nutr Cancer 1999;35:167-74.
128. Van Antwerp DJ. Suppression of TNF-α-induced apoptosis by NF-κB. Science 1997;274:787-9.
129. Vollgraf U, Wegner M, Richter-Landsberg C. Activation of AP-1 and nuclear factor-kappa B transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem 1999;73:2501-9.
130. Skulachev VP. Membrane-linked systems preventing superoxide formation. Biosci Rep 1997;17:347-65.
131. Sumantran VN, Zhang R, Lee DS, Wicha MS. Differential regulation of apoptosis in normal versus transformed mammary epithelium by lutein and retinoic acid. Cancer Epidemiol Biomarkers Prev 2000;9:257-63.
132. Toma S, Isnardi L, Raffo P, Dastoli G, De Francisci E, Riccardi L, et al. Effects of all-trans-retinoic acid and 13-cis-retinoic acid on breast-cancer cell lines: growth inhibition and apoptosis induction. Int J Cancer 1997; 70:619-27.
133. Taetle R, Dos Santos B, Akamatsu K, Koishihara Y, Ohsugi Y. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells. Clin Cancer Res 1996;2: 253-9.
134. Gianni M, Ponzanelli I, Mologni L, Reichert U, Rambaldi A, Terao M, et al. Retinoid-dependent growth inhibition, differentiation and apoptosis in acute promyelocytic leukemia cells. Expression and activation of caspases. Cell Death Differ 2000;7:447-60.
135. Delia D, Aiello A, Meroni L, Nicolini M, Reed JC, Pierotti MA. Role of antioxidants and intracellular free radicals in retinamide-induced cell death. Carcinogenesis 1997;18:943-8.
136. Zimmermann KC, Waterhouse NJ, Goldstein JC, Schuler M, Green DR. Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia 2000;2:505-13.
137. Pique M, Barragan M, Dalmau M, Bellosillo B, Pons G, Gil J. Aspirin induces apoptosis through mitochondrial cytochrome c release. FEBS Lett 2000;480:193-6.
138. Tinhofer I, Bernhard D, Senfter M, Anether G, Loeffler M, Kroemer G, et al. Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. FASEB J 2001;15:1613-5.
139. Dörrie J, Gerauer H, Wachter Y, Zunino SJ. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res 2001;61: 4731-9.
140. Mahyar-Roemer M, Katsen A, Mestres P, Roemer K. Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse. Int J Cancer 2001;94:615-22.
141. Gupta S, Ahmad N, Nieminen AL, Mukhtar H. Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells. Toxicol Appl Pharmacol 2000;164:82-90.
142. L, without alteration of p53 protein levels. Clin Cancer Res 1999;5:2971-7.
143. 2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells. Cancer Lett 1999;147:115-23.
144. Hayon T, Dvilansky A, Oriev L, Nathan I. Non-steroidal antiestrogens induce apoptosis in HL60 and MOLT3 leukemic cells;involvement of reactive oxygen radicals and protein kinase C. Anticancer Res 1999;19:2089-93.
145. Kang H-J, Soh Y, Kim M-S, Lee E-J, Surh Y-J, Kim H-RC, et al. Roles of JNK-1 and p38 in selective induction of apoptosis by capsaicin in ras-transformed human breast epithelial cells. Int J Cancer 2003; 103:475-82.
146. Lee YS, Nam DH, Kim J-A. Induction of apoptosis by capsaicin in A172 human glioblastoma cells. Cancer Lett 2000;161:121-30.
147. Lee YS, Kwon EJ, Jun DQ, Park SH, Kang YS, Huh K, et al. Redox status-dependent regulation of cyclooxygenases mediates the capsaicin-induced apoptosis in human neuroblastoma cells. J Environ Pathol Toxicol Oncol 2002;21:113-20.
148. Wolvetang EJ, Larm JA, Moutsoulas P, Lawen A. Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ 1996;7:1315-25.
149. Bíró T, Brodie C, Modarres S, Lewin NE, Ács P, Blumberg PM. Specific vanilloid responses in C6 rat glioma cells. Brain Res Mol Brain Res 1998;56:89-98.
150. Morré DJ, Sun E, Geilen C, Wu LY, de Cabo R, Krasagakis K, et al. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur J Cancer 1996;32A:1995-2003.
151. Rashmi R, Santhosh-Kumar TR, Karunagaran D. Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett 2003;538:19-24.
152. Pal S, Choudhuri T, Chattopadhyay S, Bhattacharya A, Datta GK, Das T, et al. Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma cells. Biochemn Biophys Res 2001;288:658-65.
153. Pan MH, Chang WL, Lin-Shiau SY, Ho CT, Lin JK. Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem 2001;49:1464-74.
154. Mills KI, Woodgate LJ, Gilkes AF, Walsh V, Sweeney MC, Brown G, et al. Inhibition of mitochondrial function in HL60 cells is associated with an increased apoptosis and expression of CD14. Biochem Biophys Res 1999;263:294-300.
155. Wolvetang EJ, Johnson KL, Krauer K, Ralph SJ, Linnane AW. Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett 1994; 339:40-4.
156. Kitamura Y, Inden M, Miyamara A, Kakimura J, Tanigucgi T, Shimohama S. Possible involvement of both mitochondria- and endoplasmic reticulum-dependent caspase pathways in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurosci Lett 2002;333:25-8.
157. Murillo G, Kosmeder JW, II, Pezzuto JM, Metha RG. Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest. Eur J Cancer 2002;38:2446-54.
158. Takahashi Y, Mai M, Nishioka K. α-Difluoromethylornithine induces apoptosis as well as anti-angiogenesis in the inhibition of tumor growth and metastasis in a human gastric cancer model. Int J Cancer 2000;85:243-7.
159. Jiang C, Wang Z, Ganther H, Lu J. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res 2001;61:3062-70.
160. Zhong W, Oberley TD. Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCaP human prostate cancer cell line. Cancer Res 2001;61:7071-8.
161. Sundaram N, Pahwa AK, Ard MD, Lin N, Perkins E, Bowles AP, Jr. Selenium causes growth inhibition and apoptosis in human brain tumor cell lines. J Neurooncol 2000;46:125-33.
162. Joseph B, Lefebvre O, Mereau-Richard C, Danze PM, Belin-Plancot MT, Formstecher P. Evidence for the involvement of both retinoic acid receptor- and retinoic X receptor-dependent signaling pathways in the induction of tissue transglutaminase and apoptosis in the human myeloma cell line RPMI 8226. Blood 1998;91:2423-32.
163. Ou H, Haendeler J, Aebly MR, Kelly LA, Cholewa BC, Koike G, et al. Retinoic acid-induced tissue transglutaminase and apoptosis in vascular smooth muscle cells. Circ Res 2000;87:881-7.
164. Suzuki S, Higuchi M, Proske RJ, Oridate N, Hong WK, Lotan R. Implication of mitochondria-derived reactive oxygen species, cytochrome c and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. Oncogene 1999;18:6380-7.
165. Sun SY, Li W, Yue P. Mediation of N-4-(hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res 1999;59:2493-8.
166. Lovat PE, Ranalli M, Annichiarrico-Petruzzelli M. Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma. Exp Cell Res 2000; 260:50-60.
167. Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, et al. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res 2001; 61:4879-84.
168. Zhu GH, Wong BC, Eggo MC, Ching CK, Yuen ST, Chan EY, et al. Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc. Br J Cancer 1999;79:393-400.
169. Clement MV, Hirpara. JL, Chawdhury SH, Pervaiz S. Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 1998;92:996-1002.
170. Bernhard D, Tinhofer I, Tonko M, Hubl H, Ausserlechner MJ, Greil R, et al. Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells. Cell Death Differ 2000;7:834-42.
171. Morré DJ, Bridge A, Wu LY, Morré DM. Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture. Biochem Pharmacol 2000;60:937-46.
172. Islam S, Islam N, Kermode T, Johnstone B, Mukhtar H, Moskowitz RW, et al. Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem Biophys Res 2000; 270:793-7.
173. Heerdt BG, Houston MA, Anthony GM, Augenlicht LH. Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity. Cancer Res 1999;59:1584-91.
174. Maccarrone M, Fantini C, Ranalli M, Melino G, Agro AF. Activation of nitric oxide synthase is involved in tamoxifen-induced apoptosis of human erythroleukemia K562 cells. FEBS Lett 1998;434:421-4.
175. Linford NJ, Yang Y, Cook DG, Dorsa DM. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther 2001;299:67-75.
176. Shao ZM, Alpaugh ML, Fontana JA, Barsky SH. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21(WAFI/CIP1) induction, G2/M arrest, and apoptosis. J Cell Biochem 1998;69:44-54.
177. Olah Z, Szabo T, Karai L, Hough C, Fields RD, Caudle RM, et al. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem 2001;276:11021-30.
178. Morré DJ, Chueh P-J, Morré DM. Capsaicin inhibits preferentially the NADH oxidase and growth of transformed cells in culture. Proc Natl Acad Sci USA 1995;92:1831-5.
179. Yuki K, Miyauchi T, Kakinuma Y, Murakoshi N, Suzuki T, Hayashi J, et al. Mitochondrial dysfunction increases expression of endothelin-1 and induces apoptosis through caspase-3 activation in rat cardiomyocytes in vitro. J Cardiovasc Pharmacol 2000;36:S205-8.